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1. ABSTRACT 
 
Histamine is a bioactive amine which initiates a multitude of physiological responses by 
binding to four G-protein coupled receptor (GPCR) subtypes as follows: histamine H1 
receptor (H1R), H2R, H3R and H4R. Brain histamine plays important roles in mood 
regulation, cognition and sleep-awake cycles. Extensive investigations revealed that the 
decrease of brain histamine led to various neuropsychiatric disorders such as depression and 
Alzheimer’s disease. These findings have attracted attention to brain histamine from a broad 
range of medical fields. Although it was previously thought that brain histamine mainly acted 
on neuronal cells, recent study showed the possible involvement of histamine in microglial 
functions. However, the effects of histamine on critical microglial functions such as 
chemotaxis, phagocytosis and cytokine secretion remain to be elucidated. 
Initially, I examined gene expression levels of the histamine-related enzymes and receptors 
in primary mouse microglia. Microglia expressed histidine decarboxylase (Hdc), an enzyme 
for histamine synthesis, H2R and H3R. Lipopolysaccharide (LPS) stimulation dramatically 
increased the expression level of Hdc and histamine secretion. The activation of H3R, an 
inhibitory GPCR, decreased intracellular Ca
2+
 and cAMP concentration, whereas H2R was 
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not involved in second messenger signals. Actually, H3R stimulation decreased the number of 
migrated microglia through chemotaxis chamber membranes. The number of engulfed 
microbeads by microglia was also reduced by H3R activation. In addition, H3R activation 
suppressed LPS-induced cytokines secretion.  
Next, I investigated the role of H3R in microglial functions in ex vivo and in vivo. On the 
contrary to in vitro results, H3R agonist administration increased LPS-induced cytokines 
production in in vivo microglia whereas H3R inverse agonist JNJ10181457 (JNJ) decreased 
the cytokines production. Various reports showed that the suppression of excess microglial 
activity could improve a variety of neurological disorders such as schizophrenia and 
Parkinson’s disease. Thus, I investigated the suppressive effect of JNJ on microglial functions 
by ex vivo and in vivo assays including the mouse model of human depression. First, I 
injected ATP, which is a typical chemoattractant, into hippocampal slices to investigate the 
effect of JNJ on chemotaxis. ATP-induced microglial migration toward the injected site was 
significantly suppressed by JNJ treatment. Next, I examined whether JNJ affected microglial 
phagocytosis in hippocampal slices and in the prefrontal cortex. Microglial engulfment of 
dead neurons was inhibited in the presence of JNJ. The increase in zymosan particle uptake 
by activated microglia in the prefrontal cortex was prevented by JNJ administration. Finally, I 
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investigated the role of H3R in LPS-induced mouse model of depression. In this model, LPS 
abnormally activates microglia, which subsequently secrete inflammatory cytokines leading 
to depression-like behaviors. JNJ administration inhibited IL-1β expression in microglia 
coupled with the improvement of depression-like behaviors in tail suspension tests. 
Taken together, my results demonstrate the critical roles of H3R as an important regulator in 
microglial functions, providing the novel insight into physiological roles of brain histamine. 
  
  
7 
 
2. LIST OF ABBREVIATIONS 
 
αFMH; α-fluoromethyl histidine, AC; adenylate cyclase, AD; Alzheimer’s disease, Aβ; 
amyloid-β, CB; cannabinoid receptor, CNS; central nervous system, CX3CR1; CX3C 
chemokine receptor 1, FBS; fetal bovine serum, GFAP; glial fibrillary acidic protein, GPCR; 
G-protein coupled receptor, HBSS; Hank’s balanced salt solution, Hdc; histidine 
decarboxylase, H1R; histamine H1 receptor, H2R; histamine H2 receptor, H3R; histamine H3 
receptor, H4R; histamine H4 receptor, Hnmt; histamine N-methyltransfease, HS; horse serum, 
IL-1β; interleukin-1β, IL-4; interleukin-4, IL-13; interleukin-13, JNJ: JNJ10181457, LPS; 
lipopolysaccharide, NMDA; N-methyl-D-aspartate, PGE2; prostaglandin E2, PI; propidium 
iodide, PLC; phospholipase C, SCM; slice culture medium, TNFα; tumor necrosis factor α, 
UDP; uridine 5’-diphosphate 
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3. THE MAIN ISSUES 
 
3. 1. Introduction 
The physiological properties of histamine were first described by Sir. Henry H. Dale, a 
Novel Laureate, in 1910 (Dale and Laidlaw 1910). Histamine is synthesized by 
decarboxylation of L-histidine in the reaction catalyzed by the enzyme histidine 
decarboxylase (Hdc) (Watanabe et al. 1984, Komori et al. 2012), and metabolized by 
histamine N-methyltransfelase (Hnmt) or diamine oxidase (Leitao 1954, Schwartz et al. 1991). 
Histamine exerts various actions by binding specific histamine receptors including histamine 
H1 receptor (H1R), H2R, H3R and H4R, all belonging to G-protein coupled receptors 
(GPCR) (Hosli et al. 1984, Pillot et al. 2002, Connelly et al. 2009). Extensive investigations 
about histamine have revealed diverse physiological and pathophysiological roles of 
histamine. This is evident from the worldwide success of H1R antagonists for allergy and 
H2R antagonists for peptic ulcers. (Rubitsky et al. 1950, Hartmann et al. 1996). 
In the central nervous system (CNS), histamine acts as a neurotransmitter, released from the 
histaminergic neurons. Histaminergic neurons were first confirmed by Takehiko Watanabe in 
1983 (Watanabe et al. 1983). Histaminergic neurons, which originate from the 
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tuberomammillary nucleus in the posterior hypothalamus, project to entire brain (Watanabe et 
al. 1984). Brain histamine binds to H1R and H2R in postsynaptic neurons, stimulates the 
neuronal activity, and regulates various physiological functions including sleep-wake cycles 
and aggression (Nath et al. 1982, Tasaka et al. 1989). On the other hand, H3R works as an 
autoreceptor or heteroreceptor in presynaptic neurons. In addition, H3R is the most abundant 
histamine receptor in the CNS. Consistent with its abundance and strong impact on 
neurotransmitter release, H3R is involved in diverse brain functions, such as memory, 
cognition, appetite, and arousal (Leurs et al. 1998). These findings have attracted attention 
toward H3R in the CNS from a broad range of disciplines. Preclinical and clinical trials have 
studied the therapeutic effects of H3R inverse agonists on various neurological disorders, 
such as epilepsy and attention-deficit hyperactivity disorder (Yokoyama et al. 1993, Inocente 
et al. 2012, Weisler et al. 2012). Indeed, pitolisant, an H3R inverse agonist, was approved for 
the treatment of narcolepsy by the European Medicine Agency in 2016 (Szakacs et al. 2017). 
 In addition to these actions of histamine on brain neurons, brain histamine also regulates 
the functions of astrocytes and microglia (Bader et al. 1994, Katoh et al. 2001, 
Lipnik-Stangelj and Carman-Krzan 2004). Previous reports have demonstrated that astrocytes 
obtained from various brain regions express H1R, H2R and H3R (Carman-Krzan and 
  
10 
 
Lipnik-Stangelj 2000, Juric et al. 2011). These receptors regulate glycogenolysis, intracellular 
Ca
2+
 concentration, and development of astrocytes (Rodriguez et al. 1989, Arbones et al. 
1990). Histamine also enhances the secretion of neurotrophic factors from astrocytes which 
promote neuronal survival and differentiation during development (Lipnik-Stangelj and 
Carman-Krzan 2004, Juric et al. 2011). Histamine enhances the expression of astrocytic 
glutamate transporter 1 and protects neurons against ischemic injury (Fang et al. 2014). In 
addition, astrocytes play central roles in histamine clearance in the CNS (Huszti et al. 1998, 
Yoshikawa et al. 2013). These progresses in histamine research about astrocytes have led to 
the novel insight into detailed roles of brain histamine. However, there are limited studies 
about the involvement of histamine in microglial functions (Katoh et al. 2001, Seifert et al. 
2011, Ferreira et al. 2012).  
Microglia, the brain resident immune cells, respond to a large variety of biological stimuli 
and actively perform immunological roles including production of various immune mediators, 
migration toward chemoattractants and engulfment of the debris and abnormal proteins such 
as amyloid-β (Davalos et al. 2005b, Hanisch and Kettenmann 2007). Previous reports showed 
that histamine triggered the induction of Ca
2+
, which is one of the important second 
messengers to regulate microglial functions (Bader et al. 1994). GMI6-3 cells, a cell line of 
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rat microglia, produces histamine, and N9 cells, a cell line of mouse microglia, release IL-1ß 
and migrate by histamine. (Katoh et al. 2001, Ferreira et al. 2012). These findings led to us 
assume the important roles of histamine in microglial functions. However, there are limited 
studies examining the involvement of histamine in microglial functions.  
 
 
3. 2. Objective 
In the present study, I investigated the roles of histamine receptor in microglial functions 
including chemotaxis, phagocytosis and cytokines production in vitro and in vivo. 
 
 
3. 3. Materials and methods 
Mice 
CX3C chemokine receptor 1 (CX3CR1)-GFP mice and C57BL/6j mice were purchased from 
Jackson Laboratory (Bar Harbor, ME, USA) (Jung et al. 2000) and Japan SLC (Hamamatsu, 
Japan), respectively. All experiments were performed according to the Principles for Care and 
Use of Research Animals of Tohoku University, Sendai, Japan. All experiments involving 
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animals are reported in accordance with Animal Research: Reporting of In Vivo Experiments 
guidelines (Kilkenny et al. 2010, McGrath et al. 2010). 
 
Primary microglia from neonatal mice 
Primary mouse microglia cultures were prepared from neonatal (P0−P2) mouse brain by the 
shake-off method (Tsuda et al. 2003). In brief, after removing meninges, brain tissues were 
minced and incubated at 37°C for 10 min in PBS containing 0.25% trypsin (BD Falcon, 
Franklin Lakes, NJ, USA) and 0.01% DNase I (Roche Applied Science, Upper Bavaria, 
Germany). Dissociated cells were triturated in horse serum (HS) (Life Technologies, Carlsbad, 
CA, USA) and passed through a 100 µm nylon mesh cell strainer (BD) to remove debris. The 
cell suspension was seeded at 2.0 × 10
7
 cells/flask on 150 cm
2
 flasks in Dulbecco’s modified 
Eagle medium: Nutrient mixture F12 (DMEM/F12) (Life Technologies) supplemented with 
10% foetal bovine serum (FBS) (Life Technologies), 100 μM nonessential amino acids (Life 
Technologies), 100 IU/ml penicillin G potassium (PG) (Wako, Kyoto, Japan) and 100 μg/ml 
(SM) streptomycin sulfate (Wako). Cells were maintained at 37°C in a humidified incubator 
with 10% CO2. Culture medium was changed 3 times per week. After 2 weeks cultivation, 
microglia were harvested from the medium by shaking the flasks for 3 min. 
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Immunocytochemistry 
Mixed glial cells or primary microglia cultured on cover slip were fixed and permeabilized 
with ice-cold aceton for 10 min. The cultures were stained with anti-glial fibrillary acidic 
protein (GFAP) (DAKO, Glostrup, Denmark), then incubated with FITC-conjugated 
anti-CD11b (Miltenyi Biotec, Bergisch Gladbach, Germany) and secondary anti-body: Alexa 
Fluor 568 (Life technologies) for GFAP. After adding mounting medium containing DAPI 
(Vector, Burlingame, CA, USA), fluorescent images were captured using a Nicon C2Si® 
confocal microscope (Nikon, Tokyo, Japan). 
 
Positive selection of purifying microglia for RT-PCR 
Contamination by other cell types can interfere with RT-PCR analyses of expression profiles. 
To further purify cultures prior to RT-PCR, I used the EasySep mouse CD11b-positive 
selection kit (Stemcell Technologies, Vancouver, Canada) (Gordon et al. 2011). After 
purification by the shake-off method, harvested microglia (97% CD11b-positive) were 
centrifuged at 500 × g for 5 min, resuspended at 1.0 × 10
8
 cells/ml in separation medium 
(PBS containing 2% FBS and 1 mM EDTA), and transferred to 5 ml polystyrene 
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round-bottom tubes (BD). The labelling reagent containing PE-conjugated CD11b 
monoclonal antibody (Stemcell Technologies) was added at 50 μl/ml and the cell suspension 
mixed gently and incubated at room temperature for 15 min. An anti-dextran-conjugated 
PE-Selection Cocktail (Stemcell Technologies) was then added at 70 μl/ml and the cell 
suspension mixed and incubated at room temperature for 15 min. Dextran-embedded 
magnetic nanoparticles were added at 50 μl/ml and the cell suspension mixed and incubated at 
room temperature for 10 min. The volume of the cell suspension was adjusted to 2.5 ml with 
separation medium and gently mixed. The tube was placed into the EasySep Magnet for 7 min. 
In one continuous motion, the magnet was inverted and unlabeled cells poured off. After 3 
additional washes, highly purified primary microglia were obtained for RT-PCR assays. 
 
RT-PCR analysis 
For RT-PCR, total RNA was isolated from highly purified primary microglia with or without 
lipopolysaccharide (LPS) (Sigma-Aldrich, St. Louis, MO, USA) stimulation using a 
ReliaPrep
TM
 RNA Cell Miniprep System (Promega, Fitchburg, WI, USA). Total RNA was 
reverse-transcribed with random 6 mers using a PrimeScript
®
 II 1st strand cDNA synthesis kit 
(Takara, Otsu, Japan). Diluted cDNA samples (equivalent to 5 ng total RNA) were amplified 
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with KOD FX Neo (TOYOBO, Osaka, Japan) for 40 cycles (94°C for 10 s, 60°C for 30 s, 
68°C for 30 s) using the specific oligonucleotide primers for glyceraldehyde 3-phosphate 
(GAPDH), H1R–H4R, Hdc and Hnmt (Table 1). Gene expression levels were quantified by 
densitometric analysis (Image J software) (Schneider et al. 2012), normalized against 
GAPDH expression. 
 
Histamine secretion 
Histamine secretion from microglia was measured as described (Nakamura et al. 2013). 
Microglial cells were cultured at 1.0 × 10
5
/well in 48-well plates with 100 μl of DMEM/F12 
containing 5% HS and treated with LPS or with the Hdc suicide inhibitor 
α-fluoromethylhistidine (α-FMH) as a negative control (Watanabe et al. 1990) for 24 h. HS 
was used because FBS contains a much higher concentration of histaminase, a 
histamine-degrading enzyme (Dy et al. 1982). After incubation, the medium was collected 
and assayed for histamine content. In brief, media was mixed with 8 volumes of 0.4 M 
perchloric acid (8-fold volume of medium) for deproteination. The mixture was centrifuged at 
15,000 × g for 15 min at 4°C to sediment degraded protein. Histamine in the supernatant was 
measured by a HPLC system equipped with a SC-5ODS column (3.0 i.d. × 150 mm; Eicom, 
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Kyoto, Japan) maintained at 40°C. Samples were separated using 0.1 M sodium 
dihydrogenphosphate–methanol (9:1, v/v) buffer containing 340 mg/l sodium 
1-octanesulfonate at a flow rate of 500 µl/min. After mixing with 80 mg/l O-phthalaldehyde 
solution (flow rate: 100 µl/ml) and 0.5 M potassium carbonate solution (flow rate: 100 µl/ml), 
fluorescence from histamine was excited at 340 nm and measured at 450 nm. 
 
Measurement of intracellular cAMP concentration 
Intracellular cAMP concentration was measured as described (Taylor et al. 2003). Microglia 
were pre-incubated in Hank’s balanced salt solution (HBSS) (Life Technologies) containing 1 
mM the phosphodiesterase inhibitor 3-isobutyl-1-metylxanthine (Nakalai Tesque, Kyoto, 
Japan) in the presence of amthamine (2–200 µM), imetit (0.1–10 nM) or histamine (0.1–100 
µM) (all from Sigma-Aldrich) for 30 min at 37°C. Microglia were then stimulated with 25 
µM forskolin (Wako), an activator of adenylate cyclase, for 30 min at 37°C. Treated cells 
were lysed and sonicated in 0.1 M ice-cold HCl. After centrifugation to remove degraded 
protein, cAMP was measured using a cAMP EIA kit (Cayman Chemical Co., Ann Arbor, MI, 
USA). 
 
  
17 
 
Measurement of intracellular Ca
2+
 concentration 
Intracellular Ca
2+
 concentration was measured using the Ca
2+
-sensitive fluorescent dye 
fluo-8/AM (ABD Bioquest Inc, Sunnyvale, CA USA) as described previously with minor 
modifications (Parvathenani et al. 2003). Microglia were seeded into 96-well clear bottom 
plates (Greiner Bio-One, Frickenhausen, Germany) at a density of 3 × 10
4
 cells/well and 
loaded with 5 μM fluo-8/AM for 30 min at room temperature in HBSS. After dye loading, 
microglia were washed and incubated in HBSS for 10 min at room temperature to allow 
cleavage of intracellular fluo-8/AM by endogenous esterases. Fluo-8 fluorescence was 
measured on a Flexstation® 3 microplate reader (Molecular Devices, Sunnyvale, CA, USA) 
with excitation at 490 nm and emission at 518 nm. After a 30-s measurement of baseline 
fluorescence in the presence or absence of histamine, amthamine or imetit, ATP or histamine 
were automatically injected into each well. Fluorescent intensity was recorded and analysed 
using a Softmax Pro 6 software (Molecular Devices). Fluorescence emission before fluo-8 
loading was subtracted as background. 
 
In vitro chemotaxis assay 
Chemotaxis assays were performed using a Transwell
TM
 Permeable Supports (Corning Inc., 
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Corning, NY, USA) (6.5 µm diameter insert, 8.0 µm pore size, polycarbonate membrane) as 
described (Ryu et al. 2009). Microglia (1.0 × 10
5
 cells) in serum-free DMEM/F12 were 
seeded in the upper chambers and the lower chambers were filled with DMEM/F12 plus 1% 
FBS containing 100 μM ATP alone, histamine (0.1–10 μM), imetit (0.1–10 nM) or the 
selective antagonist thioperamide (1 μM) plus histamine (10 μM). After 16 h incubation at 
37°C, the medium was removed and non-migrated cells on the upper surface of the membrane 
were wiped away using cotton swabs. The membranes were washed twice with 0.1 M sodium 
phosphate buffer (pH 6.4) and fixed with 100% methanol at −20°C for 20 min. Migrated cells 
on the underside of the membrane were visualized with Giemsa stain (Merck KGaA, 
Darmstadt, Germany) and counted by a BZ-9000 microscope (Keyence, Osaka, Japan) and 
the images analysed by Hybrid Cell Count image analysis software (Keyence). 
 
In vitro phagocytosis assay 
Phagocytosis was assayed by measuring the uptake of fluorescent microspheres (Uesugi et al. 
2012). Microglia on glass cover slips were incubated with 100 μM uridine 5′-diphosphate 
(UDP) (Wako) alone, histamine (0.1–10 μM), imetit (0.1–10 nM) or thioperamide (1 μM) 
plus histamine (10 μM) at 37°C for 1 h. Next, FluoSpheres (red fluorescence, 2.0 µm in 
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diameter; Life Technologies) were added to the medium (0.001% w/w) and cultures incubated 
for 45 min at 37 °C. Microglia were then fixed with 4% paraformaldehyde (PFA), 
permeabilized with 0.5% Triton-X100 and stained with anti-actin phalloidin (green 
fluorescence) (Cytoskeleton Inc., Denver, CO, USA) and DAPI. Fluorescent images were 
captured with a confocal microscope. For morphometric analysis, fluorescent images were 
captured by a fluorescent microscope and analysed by appropriate software (Keyence). 
 
Measurement of mRNA expression level of tumor necrosis factor α and prostaglandin E2 
synthase and Hdc in vitro 
Microglia were seeded into 24-well plates at 2 × 10
5
 cells/well and pre-incubated in 
serum-free DMEM/F12 in the presence of histamine (0.1–10 μM), imetit (0.1–10 nM), or 
thioperamide (1 μM) plus histamine (10 μM) for 2 h. After pre-incubation, microglia were 
stimulated with 10 ng/ml LPS for 6 h. After total RNA isolation, the mRNA expression level 
of TNFα, PGE2 synthase and Hdc were measured by quantitative real-time RT-PCR method. 
 
TNFα and PGE2 measurement in vitro 
Microglia were seeded into 96-well plates at 3 × 10
4
 cells/well and pre-incubated in 
  
20 
 
serum-free DMEM/F12 in the presence of histamine (0.1–10 μM), imetit (0.1–10 nM), or 
thioperamide (1 μM) plus histamine (10 μM) for 2 h. After pre-incubation, microglia were 
stimulated with 10 ng/ml LPS for 24 h. The concentrations of tumour necrosis factor-α 
(TNFα) and prostaglandin E2 (PGE2) in the medium were measured by a TNFα ELISA kit 
(Shibayagi, Gunma, Japan) and a PGE2 EIA kit (Cayman Chemical).  
 
Measurement of mRNA expression level of TNFα, PGE2 synthase for in vivo microglia 
 Mice were injected with saline, LPS (1 mg/kg), LPS plus immethridine (10 mg/kg) (Tocris 
Bioscience; Bristol, UK) or LPS plus JNJ10181457 (JNJ) (10 mg/kg) (Tocris). Immethridine 
and JNJ are highly specific and blood brain barrier permeable reagents rather than imetit and 
thioperamide. Four hours after the injection, mice were sacrificed. After microglial isolation 
from whole brain, Total RNA was isolated and the mRNA expression level of TNFα, PGE2 
synthase were measured by quantitative real-time RT-PCR method. 
 
Microglial isolation from adult mouse brain 
Microglial isolation was performed as previously described, with minor modifications 
(Cardona et al. 2006). Brain tissues were minced and exposed to collagenase (final 
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concentration: 1 mg/mL) (Roche) for 20 minutes at 37ºC. The tissues were then incubated 
with DNase І solution for 5 minutes at 37ºC. Dissociated cells were passed through a 100-μm 
nylon mesh cell strainer and centrifuged at 600 × g for 5 minutes at 4ºC. After removal of 
debris, cells were resuspended in 30% percoll (GE Healthcare; Princeton, NJ, USA) solution 
and centrifuged for 10 minutes at 700 × g. At least 90% of the pelleted cells were 
immunopositive for the microglial marker CD11b. 
 
Organotypic hippocampal slice cultures 
Organotypic hippocampal slices were prepared as described previously (Hanson et al. 2007). 
The hippocampus was removed from the brain of CX3CR1-GFP mice pups (P6-10). The 
hippocampal slices were prepared by cutting into 120- (for chemotaxis assay) or 
350-μm-thick (for ex vivo phagocytosis assay) using a MacIlwain tissue chopper (Mickle 
Laboratory Engineering; Gomshall Lane, UK). 
 
Ex vivo chemotaxis assay 
Hippocampal slices were pre-incubated with or without 10 μM JNJ containing dissection 
buffer with the following composition: Modified Eagle’s Medium (MEM)/HBSS (Life 
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Technologies), 10 mM Tris-HCl (pH 7.2), 25 mM HEPES supplemented with 100 IU/mL PG 
and 100 μg/ml SM. Injection of 3 mM ATP was performed using a microinjector (BJ-110; 
BEX; Tokyo, Japan) with the following specifications: diameter of pipette tip, 8 μm; pressure, 
0.04 MPa; duration, 100 msec. Images were captured every 30 seconds using a fluorescent 
microscope (IX-71; Olympus; Tokyo, Japan). Microglial chemotaxis was analyzed as 
described previously (Davalos et al. 2005a). Briefly, the fluorescent intensity in region Rx 
(100 μm in radius from the injected site) at each time point Rx(t) was subtracted from the first 
image Rx(0). Microglial chemotaxis at any time point is calculated using the equation Rx(t) – 
Rx(0). 
 
Ex vivo phagocytosis assay 
The hippocampal slices were pre-incubated for 1 hour at 37ºC with slice culture medium 
with the following composition: 50% MEM/HBSS, 25% HBSS, 25% HS, and 25 mM HEPES 
supplemented with 100 IU/mL PG and 100 μg/ml SM. After stimulation with 50 μM 
N-methyl-D-aspartate (NMDA) (Tokyo Chemical Industry; Tokyo, Japan) in the presence or 
absence of 1 μM JNJ for 3 hours, the slices were incubated with 0.5 μg/ml of propidium 
iodide (PI) (Tokyo Chemical Industry), which is a membrane-impermeable fluorescent dye 
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for DNA, with or without 1 μM JNJ for 21 hours. Fluorescent images were captured using a 
confocal microscope. Microglial phagocytosis was evaluated using Bz-9000, and the images 
were analyzed appropriate software (Keyence).  
 
Immunohistochemistry for CD68 
The fixed slices were incubated with a primary antibody for CD68 (Abcam; Cambridge, 
UK) in 20% bovine serum albumin (Sigma-Aldrich) in PBS overnight at 4ºC. The sections 
were then treated with a secondary antibody conjugated with Allexa Fluor 594 (Life 
Technologies). 
 
In vivo phagocytosis assay 
In vivo phagocytosis was assayed as described previously (Koizumi et al. 2007b). 
Yeast-derived zymosan particles conjugated with Alexa 568 (Thermo Fisher Scientific Inc.; 
Waltham, MA, USA) was stereotaxically injected into the prefrontal cortex at the following 
coordinates: anterior, 0.3 mm; lateral, ± 1.2 mm; and ventral, 1.6 mm from bregma. I 
intracranially co-administered 10 μg/uL of LPS and/or 10 μM JNJ with the zymosan particles. 
I injected the mice with 10 mg/kg JNJ or saline intraperitoneally for the next 3 consecutive 
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days. Four days after the zymosan injection, brain coronal sections (50-μm-thick) were 
prepared using a vibratome (Leica; Wetzlar, Germany) after perfusion with 4% PFA. 
Phagocytosis was quantified by counting the numbers of engulfed beads in microglia using a 
fluorescent microscope and appropriate software (Keyence). 
 
Tail suspension test 
Mice were intraperitoneally injected with saline, LPS (1 mg/kg), JNJ (10 mg/kg), or both 
LPS and JNJ. Four hours after the injection, a tail suspension test was performed as 
previously described with minor modifications (Liu et al. 2016). Mice were suspended 50 cm 
above the floor by holding their tails using a clip. The immobility time over the 6-minute test 
was recorded and analyzed. After tail suspension test, the brain was removed and mRNA 
expression level of interleukin-1β in isolated adult microglia and amount of IL-1β protein 
were measured. 
 
Measurement of IL-1β protein levels 
Brain tissues were homogenized in 50 mM Tris-HCl buffer containing 1 mM EDTA (pH 7.4) 
and centrifuged at 1,000 × g for 10 minutes at 4ºC. The supernatants were centrifuged at 
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20,000 × g for 40 minutes at 4ºC to remove remaining debris. Total protein and IL-1β levels 
was determined using a bicinchoninic acid assay kit (Thermo) and an IL-1β ELISA kit (R & 
D systems; Minneapolis, MN, USA), respectively. 
 
Statistical analysis 
 Treatment group means were compared by Student’s t-test or one-way ANOVA using a 
Prism 5 software (Graphpad, La Jolla, CA, USA). Results are expressed as means ± standard 
errors. P-values less than 0.05 were considered significant. 
 
 
3. 4. Results 
Analysis of the purity of primary mouse microglia 
I analyzed the purity of cells by immunocytochemistry and flow cytometry. As shown in 
Figure 1, almost primary cultures are CD11b (microglial marker protein)-positive and GFAP 
(astrocytic marker protein)-negative compared with mixed glial cultures.  
 
Primary mouse microglia expressed H2R, H3R, Hdc and Hnmt 
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I examined the expression of histamine related genes in the mouse primary microglia in the 
presence or absence of LPS by RT-PCR. Of the four known histamine receptors, I detected 
H2R and H3R (Figure 2A). In addition, primary mouse microglia expressed Hdc, which is an 
essential enzyme for histamine synthesis, and Hnmt, the histamine metabolizing enzyme. 
Although H1R was detected in one lane, it might be because contamination of astrocytes 
which highly expressed H1R. The result of densitometric analysis showed that expression 
level of H2R and Hdc increased in LPS stimulated groups (Figure 2B). In contrast, the 
expression level of Hnmt decreased by LPS stimulation. 
 
Histamine production was induced by LPS stimulation  
In the CNS, histaminergic neurons are considered the main source of histamine synthesis 
and secretion. However, Katoh et al showed that LPS could induce histamine production from 
a microglial cell line (Katoh et al. 2001). The quantitative real-time PCR analysis showed that 
the mRNA expression level of Hdc was dramatically increased by LPS in primary microglia 
(Figure 3A). In addition, histamine secretion from the primary microglia was also elevated by 
LPS, whereas the Hdc inhibitor α-FMH (10 μM) abolished LPS-induced histamine production 
(Figure 3B).  
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Expression of functional H3R by microglia 
Ligand binding to histamine receptor activates cAMP- and Ca
2+
-dependent second 
messenger pathways (Takeshita et al. 1998, Lovenberg et al. 1999). To confirm expression of 
functional histamine receptor in microglia, I examined the effects of H2R and H3R agonists 
on intracellular cAMP and Ca
2+
 concentrations.  
The H2R is coupled to Gs, which actively regulates adenylate cyclase (AC) (Gantz et al. 
1991), whereas the H3R is coupled to Gi, which negatively regulates AC (Lovenberg et al. 
1999). Therefore, activation would be expected to regulate cAMP production. H3R-specific 
agonist imetit reduced cAMP accumulation induced by the AC activator forskolin whereas 
H2R specific agonist amthamine had no effect on intracellular cAMP concentration (Figure 
4A). Histamine did not change the cAMP accumulation (Figure 4B). 
Acute addition of histamine did not affect basal Ca
2+
 concentration (Figure 5A). In contrast, 
as shown in figure 5B, imetit reduced the peak and duration of the intracellular Ca
2+
 signals 
induced by 1 mM ATP. Amthamine had no effect on the intracellular Ca
2+
 signals. Low 
concentration of histamine (10 µM), which can activate only H3R (Ki of histamine to mouse 
H3R: 15 nM) (Strasser et al. 2013), also reduced intracellular Ca
2+
 concentration, although 
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high concentration (250 µM) of histamine activating both of H2R and H3R (pEC50 of 
histamine to rat H2R: 5.92) (Strasser et al. 2013) did not affect intracellular Ca
2+
 
concentration. Considering the ubiquity of cAMP- and Ca
2+
-initiated signalling pathways in 
mediated histaminergic responses, I speculated that suppression of these pathways caused by 
H3R but not H2R activation would have broad effects on critical microglial functions, as 
confirmed in subsequent experiments 
 
Chemotaxis was suppressed by H3R activation 
Chemoattractants leaked from injured neurons stimulate microglial movement (chemotaxis) 
toward the site of injury (Davalos et al. 2005b). I examined the effect of H3R activation on 
microglial chemotaxis by counting the number of microglia crossing a transwell membrane in 
the presence or absence of H3R agonists. Both histamine and imetit caused a dose-dependent 
inhibition of microglial migration toward chemoattractants in the bottom well compared to 
the control group (Figure 6). Furthermore, the H3R antagonist thioperamide reversed this 
suppressive effect of H3R activation on chemotaxis. 
 
Phagocytosis was suppressed by H3R activation 
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Phagocytosis of microglia is regulated by both receptor tyrosine kinases and GPCRs (Inoue 
2007, Napoli and Neumann 2009). I examined whether H3R activation affected microglial 
phagocytosis by monitoring uptake of fluorescent microspheres (Koizumi et al. 2007a). Both 
histamine and imetit inhibited the engulfment of microspheres in a dose-dependent manner 
(Figure 7) and this inhibition was abolished by thioperamide. 
 
Microglial TNFα and PGE2 secretion were suppressed by H3R activation 
LPS promote the secretion of pro-inflammatory cytokines from microglia. Conversely, 
several neurotransmitters suppress LPS-induced pro-inflammatory responses, including 
cytokines secretion (Chang and Liu 2000). Therefore, I examined whether H3R activation 
suppressed LPS-induced cytokine production in the primary microglia. Treatment with LPS 
elicited TNFα and PGE2 synthase mRNA expression and TNFα and PGE2 secretion in 
microglia, and this pro-inflammatory response was suppressed dose-dependently by both 
histamine and imetit (Figure 8A–D). Thioperamide again abolished the inhibitory effects of 
histamine. These results suggested that H3R activation suppressed LPS-induced inflammatory 
response. 
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The opposite effect of H3R activation on microglial TNFα and PGE2 production in vivo 
 I demonstrated that H3R activation decreased microglial functions in vitro. Next, I examined 
the role of H3R in microglial functions by ex vivo and in vivo assays. I investigated whether 
H3R activation suppressed microglial TNFα and PGE2 production in vivo. LPS injection 
dramatically increased the mRNA expression level of TNFα and PGE2 synthase in primary 
microglia. Interestingly, the elevated-TNFα and -PGE2 synthase expression were additionally 
increased by immethridine, a selective H3R agonist, treatment whereas JNJ10181457 (JNJ), a 
selective H3R inverse agonist, suppressed TNFα and PGE2 synthase expression (Figure 9). 
Previous reports showed that the suppression of excess microglial activity could improve a 
variety of neurological disorders (O'Connor et al. 2009). Thus, I investigated the suppressive 
effect of JNJ on microglial functions by ex vivo and in vivo assays including the mouse model 
of human depression.  
 
JNJ suppressed microglial chemotaxis in hippocampal slices 
Since ATP leakage from injured cells is a strong chemoattractant and induces microglial 
migration, I examined the effects of JNJ on chemotaxis in response to local ATP injection into 
acute hippocampal slices. Although capillary insertion slightly induced microglial movement, 
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ATP administration significantly promoted microglial migration to the injection site (Figure 
10A and B). In the presence of JNJ, microglial responses to ATP were significantly reduced. 
This demonstrates that JNJ has an inhibitory effect on microglial chemotaxis. 
 
JNJ suppressed phagocytosis of dead cells in hippocampal slices 
To investigate the effects of JNJ on microglial phagocytosis in hippocampal slices, I induced 
neuronal death using NMDA and evaluated the microglial engulfment of dead neurons. The 
numbers of PI-positive neuronal nuclei in the microglia were reduced following JNJ 
administration, suggesting that JNJ inhibits phagocytosis activity of microglia (Figure 11A 
and B). I also evaluated the expression of CD68, which is a marker of phagocytic microglia 
(Zotova et al. 2011). Protein and mRNA expression levels of CD68 were also suppressed in 
JNJ-treated hippocampal slices (Figure 11C–E). These results suggest that JNJ inhibits the 
phagocytic activity of microglia in hippocampal slices. 
 
In vivo phagocytosis was inhibited by JNJ 
I injected yeast-derived zymosan particles into the prefrontal cortex of the mice to 
investigate the effects of JNJ on in vivo phagocytosis. LPS significantly increased the 
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numbers of zymosan particles engulfed by microglia (Figure 12A and B). JNJ did not affect 
zymosan engulfment in the absence of LPS stimulation, but completely abolished the increase 
in phagocytosis following LPS administration. These results indicate that JNJ reduces 
microglial engulfment in the inflammatory conditions induced by LPS treatment. 
 
JNJ treatment suppressed microglial activation and improved depression-like behavior 
Abnormal microglial activation exacerbates various neurological disorders, including 
depression (Steiner et al. 2008). In contrast, normalization of excessive microglial activity has 
therapeutic effects on neuropsychiatric diseases (O'Connor et al. 2009). I examined whether 
inhibitory effects of JNJ on microglia could improve depression-like behavior in mice. The 
prolongation of immobile time induced by LPS in the tail-suspension test was attenuated 
following JNJ treatment (Figure 13A). In addition, IL-1β protein, which is a key cytokine 
responsible for depression-like behaviors, was especially significantly decreased in the 
presence of JNJ (Figure 13B). Since LPS-induced depression-like behavior is mediated by 
cytokine secretion from abnormally activated microglia, I examined whether JNJ suppressed 
LPS-induced IL-1β production in microglia. JNJ attenuated LPS-induced increases in the 
expression levels of IL-1β in isolated adult microglia (Figure 13C). These results indicate that 
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JNJ has an inhibitory effect on microglial activation and improves depression-like behavior in 
mice. 
 
 
4. 5. Discussion 
I demonstrate that primary mouse microglia express functionally active H3R and Hdc, and 
that stimulation of microglial H3R suppress three critical activities, chemotaxis, phagocytosis 
and cytokines production. Additionally, I reveal the inhibitory effects of JNJ on microglial 
cytokines production, chemotaxis and phagocytosis using ex vivo and in vivo assays. I also 
indicate that JNJ improves depression-like behavior with decreasing IL-β production in the 
mouse brain.  
First, I found only H2R and H3R expression in primary mouse microglia using RT-PCR 
under basal and LPS-stimulated conditions (Figure 2). On the other hands, the mouse 
microglial cell line N9 expressed H2R, H3R and H4R (Ferreira et al. 2012), Similarly, 
Strakhova et al. reported H4R expression in rat neurons but not glial cells by RT-PCR 
(Strakhova et al. 2009). Microglial receptor expression patterns differ according to brain 
region (Olah et al. 2011) and the current isolation procedure excluded microglia from 
cerebellum and spinal cord. Thus, I cannot rule out the possibility that microglia purified from 
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cerebellum and spinal cord express H4R. N9 cells might change to express H4R in the 
process of immortalization. Microglia are characterized by a classical pro-inflammatory M1 
type or an alternative anti-inflammatory and tissue repairing M2 type, each with a specific 
function and pattern of marker expression (David and Kroner 2011). In this study, I 
investigated the histamine receptor expression in M1 microglia which were induced by LPS 
stimulation (Nagai et al. 2002). Although histamine receptors and histamine related-enzymes 
expression profiles in M2 microglia might be different from M1 microglia, the profiles remain 
to be elucidated. 
My results showed that LPS enhanced the expression level of Hdc and suppressed that of 
Hnmt in primary mouse microglia, suggesting histamine production was regulated by these 
two enzymes. Indeed, I demonstrated that microglia released histamine in response to the 
inflammatory response activator LPS. Moreover, an Hdc inhibitor, α-FMH, completely 
abolished LPS-induced histamine secretion, supporting that histamine was enzymatically 
synthesized following LPS stimulation. These results are consistent with a previous report on 
a microglial cell line (Katoh et al. 2001) and indicate that microglia are an additional source 
of histamine in the CNS. In addition to inflammation, it was reported that histamine from 
brain-resident mast cells regulated wakefulness and anxiety (Chikahisa et al. 2013). Recent 
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reports also showed that microglia contain a molecular clock (Hayashi et al. 2013), indicating 
that histamine from microglia could be involved in the regulation of wakefulness and other 
circadian behaviors. 
Detection of receptor mRNA does not guarantee the expression of functional receptors 
linked to appropriate downstream signalling pathways (Greenbaum et al. 2003); therefore, I 
confirmed functional expression and downstream second messenger generation. I 
demonstrated that H3R activation by the specific agonist imetit inhibited second messengers, 
although H2R activation by amthamine did not affect the intracellular signals. RT-PCR assay 
using only oligo dT primers in the reverse transcription did not detect H2R mRNA expression, 
suggesting poly(A) tail was not added to most H2R mRNA. Because poly(A) tail is important 
for the stabilization of mRNA, H2R mRNA might be immediately degraded before the 
translation and the amount of H2R protein could not be enough to function.   
As shown in figure 4, H3R activation with imetit decreased forskolin-induced cAMP 
accumulation in microglia, suggesting that H3R in microglia was coupled to Gi proteins and 
negatively regulated cAMP concentration. Although cAMP level controls various cellular 
functions, the roles of cAMP in microglia remain to be elucidated. For example, the effects of 
cAMP increase on IL-1β (Woo et al. 2004, Liu et al. 2011, Quan et al. 2013, Jin et al. 2014) 
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and IL-6 (Si et al. 1998, Hashioka et al. 2007) were different among studies. On the other 
hand, almost all reports agreed that intracellular Ca
2+
 concentration played a key role in 
cytokine production (Espinosa-Parrilla et al. 2014, Sun et al. 2014). In our study, both of 
imetit and histamine reduced intracellular Ca
2+
 concentration, while only imetit could affect 
folskolin-induced cAMP increase. These results suggested the activation of H3R might 
regulate cytokine production predominantly via Ca
2+
 dependent pathways but not cAMP. 
Further studies are necessary to examine the importance of H3R-mediated effect on cAMP 
concentration.  
I demonstrated that low concentration (10 M) of histamine inhibited ATP-induced 
intracellular calcium transient, whereas high concentration (250 M) of histamine had no 
effect on this increase. Various reports showed that high concentration of histamine (over 
100µM) could bind to NMDA receptors and GABAA receptors (Saras et al. 2008, Burban et al. 
2010), and microglia express these receptors (Lee et al. 2011, Kaindl et al. 2012). High 
concentrations of histamine might also activate NMDA receptors and/or GABAA receptors 
and affect ATP-induced intracellular signalling pathway. 
Although acute addition of histamine did not change basal Ca
2+
 concentration (Figure 5A), 
Seifert et al. reported that histamine induced Ca
2+
 transients in microglia in situ (Seifert et al. 
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2011). They measured Ca
2+
 concentration in situ, an extracellular environment distinct from 
our in vitro experiments. In schwann cells, an ATP-induced Ca
2+
 increase occurred in situ but 
not in vitro because neuronal contact is essential for this response to ATP (Lyons et al. 1995). 
Contact with other cells or with the extracellular matrix may also affect the Ca
2+
 response to 
histamine in microglia, a possibly that remains to be examined.  
Histamine dose-dependently suppressed chemotaxis, phagocytosis and cytokine secretion 
through H3R, a Gi-coupled receptor (Figure 6, 7 and 8). Activation of Gi-coupled CB2 also 
decreased ATP-induced increase in intracellular Ca
2+
 concentration (Martin-Moreno et al. 
2011) and suppressed microglial functions including chemotaxis (Romero-Sandoval et al. 
2009), phagocytosis (Ehrhart et al. 2005) and cytokine secretion (Klegeris et al. 2003). In 
addition, activation of the sigma receptor coupled to Gi protein attenuated Ca
2+
 mobilization 
in microglia, leading to inhibition of migration and reduction of cytokine release (Hall et al. 
2009). Conversely, P2Y12 receptor, a Gi-type GPCR, induced Ca
2+
 mobilization via the 
phospholipase C pathway and facilitated chemotaxis (Irino et al. 2008). These findings 
indicated that the intracellular Ca
2+
 concentration might predominantly contribute to the 
microglial functions. 
LPS develops microglia to M1 phenotype, including increase in production of 
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pro-inflammatory molecules such as TNFα, IL-1β and prostaglandins. H3R activation 
suppressed LPS-induced TNFα and prostaglandin E2 production, indicating that microglial 
pro-inflammatory M1 activation were mediated via H3R. On the other hand, M2 microglia 
are induced by interleukin-4 (IL-4) and interleukin-13 (IL-13) treatment and produce 
anti-inflammatory molecules such as insulin-like growth factor 1 and arginase 1 (Ferreira and 
Bernardino 2015). M2 microglia also have highly chemotactic and phagocytic activities for 
tissue repairing (Lively and Schlichter 2013, Zhao et al. 2015). Although the role of the H3R 
activation in M2 microglial functions should also be elucidated, I revealed suppressive effect 
of H3R activation on microglial chemotactic and phagocytic activities, suggesting that H3R 
activation might also decrease M2 microglial functions.  
Contrary to the studies of primary mouse microglia, H3R inverse agonist suppressed 
microglial functions in vivo. The one possibility is the distinct experimental systems. In in 
vitro cytokine production experiment, microglia are directly stimulated by LPS application. 
On the other hand, in vivo microglia are activated by pro-inflammatory cytokines secreted 
from peripheral immune cells because LPS scarcely penetrate blood brain barrier by 
intraperitoneal injection (Singh and Jiang 2004, Banks and Robinson 2010). This 
experimental difference might alter the effect of H3R activation on cytokines production. In 
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addition, systemic injection of H3R inverse agonist could affect not only microglia but other 
H3R expressing cells including neuron and astrocytes (Arrang et al. 1983, Juric et al. 2011). 
In the brain, neurons around microglia secrete neurotransmitters, such as norepinephrine and 
serotonin, which considerably alter microglial activity. Serotonin reduces microglial 
phagocytosis and norepinephrine suppresses ATP-induced process extension and LPS-induced 
inflammatory factors secretion (Dello Russo et al. 2004, Krabbe et al. 2012, Gyoneva and 
Traynelis 2013). Therefore, H3R inverse agonist increase the release of such 
neurotransmitters (Esbenshade et al. 2008), might leading to the suppressive effect of H3R 
inverse agonist on in vivo microglial functions. In addition to the regulation of microglial 
functions by neurotransmitters, neurons are also indirect contact with microglia via the 
interaction between CD200 and the CD200 receptor, which leads to the inhibition of 
microglia (Hoek et al. 2000). Indeed, brain-resident microglia and primary microglia isolated 
from the neonatal cortex have different properties, including gene expression patterns 
(Schmid et al. 2009). These lines of evidence demonstrate the strong impact of the local 
environment on microglial activity, suggesting that distinct extracellular microenvironments 
might contribute to the different roles of H3R in microglial functions in vitro and in vivo. 
Microglial functions, such as chemotaxis and phagocytosis, are essential for the maintenance 
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of a healthy CNS. However, under pathological conditions, such as Alzheimer’s disease and 
schizophrenia, abnormally activated microglia have devastating effects on neurons through 
excessive synaptic pruning and elimination of healthy neurons, which in turn leads to disease 
progression (Boksa 2012, Brown and Neher 2014, Hong et al. 2016). Thus, silencing 
abnormal microglia enhances neuronal viability and survival and alleviates various 
neuropsychiatric disorders (Hong et al. 2016). Indeed, Webster et al. have shown that 
excessive activation of microglia during brain ischemia exacerbates brain damage, and that 
the inhibition of microglial chemotaxis to ischemic regions prevents neuronal death (Webster 
et al. 2013). Moreover, blockade of abnormal phagocytosis in animal models of Alzheimer’s 
disease dramatically reduces neuronal loss and improves neurotransmission (Neniskyte et al. 
2011, Hong et al. 2016). Previous studies using H3R inverse agonists have shown their 
therapeutic potential in CNS diseases, and the present study describes the inhibitory effects of 
JNJ on chemotaxis and phagocytosis. These lines of evidence indicate that microglial 
inhibition by H3R inverse agonists might have therapeutic benefit in neuropsychiatric 
disorders, such as brain ischemia and Alzheimer’s disease, although further studies are 
necessary to examine the roles of microglial H3R in animal models of human brain diseases. 
Microglial functions and pattern of marker expression profiles are distinct in brain region 
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(Hanisch 2013, Grabert et al. 2016). The genome wide analysis has shown that hippocampal 
and cerebellar microglia have relatively greater expression than microglia in striatum in the 
energy production profiles (mitochondrial biogenesis, glycolysis, TCA cycle, electron 
transport chain and ATP synthesis), which affect high energy requirement microglial 
behaviors such as chemotaxis and phagocytosis (Bernhart et al. 2010). In this study, I used 
hippocampal slices for ex vivo chemotaxis and phagocytosis assays. The results might be 
different in the slices from striatum where microglia might have low chemotactic and 
phagocytic activities. 
Recent studies indicated that the increase in inflammatory cytokines secreted from activated 
microglia played causative roles in depression (Steiner et al. 2008, Lee et al. 2013). Especially, 
IL-1β, a key pro-inflammatory cytokine, is up-regulated in the brain of patients with 
depression and inhibition of IL-1β signal is sufficient to prevent depression-like behavior 
(Goshen et al. 2008, Koo and Duman 2009). I demonstrated that JNJ suppressed LPS-induced 
microglial IL-1β expression and IL-1β protein in the brain. Thus, the inhibitory effect of JNJ 
on cytokines secretion from activated microglia contributed to the reduction of 
depression-like behaviors.  
This study has some limitations which have to be pointed out. I revealed that LPS-induced 
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M1 activation was suppressed by H3R activation in primary microglia. JNJ also suppressed 
M1 activation including LPS-enhanced cytokines production and phagocytosis in vivo. 
However, the role of H3R in M2 microglia remain to be elucidated. The regulation of M2 
activation is essential for wound healing and clearance of misfolded proteins in brain. During 
sublethal ischemia in the focal brain ischemic model mice, local neurons produce IL-4 (Zhao 
et al. 2015). Released IL-4 and peroxisome proliferator activated factor γ agonist polarizes 
microglia from a pro-inflammatory M1 phenotype to a healing M2 phenotype, improving 
neuronal injury and stroke in the model (Zhao et al. 2015). Moreover, M2 activation by IL-4 
and IL-13 treatment decreased amyloidβ deposition in the cerebral cortex and improved 
cognitive functions in mouse model of Alzheimer’s disease (Kawahara et al. 2012). Thus, the 
elucidation of the role of H3R in M2 microglia might lead to good understanding of brain 
histaminergic system and therapy for neurological disorders. In in vivo studies, JNJ was 
systemically used for assays. I could not rule out the possibility that JNJ also affected other 
cell types and altered microglial functions. Thus, microglial specific H3R deletion using a 
conditional knockout strategy should be used to demonstrate the role of microglial H3R in 
chemotaxis, phagocytosis and cytokines production in vivo, and in depression-like behaviors. 
Moreover, I investigated the effect of JNJ on depression using LPS-induced depression 
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models. Intraperitoneal injection of LPS causes systemic inflammation, accompanying 
pro-inflammatory cytokines production in peripheral immune cells. These cytokines directly 
act on the brain to cause not only depression-like behaviors but sickness behaviors, 
accompanying anxiety and anhedonia (Dantzer et al. 2008). Thus, the increased immobility 
time in tail suspension test could not be distinguished a depression-like behavior from a 
sickness behavior. Therefore, other behavioral tests such as preference and anxiety based tests 
should be also performed using other depression models known as chronic stress models, 
social defeat models and learned helplessness models to elucidate the therapeutic effect of 
JNJ on depression. Microglial activation in hippocampus and medial prefrontal cortex is 
occurred in depression (Tynan et al. 2010, Wohleb et al. 2013). Thus, brain region specific 
analysis for microglial morphologies and functions should be also performed for better 
understanding of the involvement of microglial H3R in depression. 
 
 
3. 6. Conclusion 
In the present study, my pharmacological experiments demonstrated the role of microglial 
H3R in vitro and in vivo. Primary mouse microglia expressed functionally active H3R and 
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Hdc. Microglia enzymatically produced histamine and activation of H3R regulated 
chemotaxis, phagocytosis and cytokine secretion. In addition, JNJ10181457, a H3R inverse 
agonist, has an inhibitory role in in vivo microglial functions, leading to improvement of 
LPS-induced depression-like behavior with decreasing IL-1β protein expression in the mouse 
brain. Our finding could promote better understandings of CNS disorders involved in the 
brain histaminergic system and might lead to the development of new drugs that target 
microglial H3R. 
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5. TABLE 
 
Table 1. Primer sequences for PCR (*: primers for real-time PCR) 
Gene Primer Sequence Product Size (bp) 
GAPDH 
Sense 
Antisense 
 
5’-TGACAACTTTGGCATTGTGG-3’ 
5’-ACCCTGTTGCTGTAGCCGTA-3’ 
 
477 
H1R 
Sense 
Antisense 
 
5′-CAGACACCAGCATAGAGCCA-3′ 
5′-ACCGAGATCGACCACAGAC-3′ 
 
523 
H2R 
Sense 
Antisense 
 
5′-TCTTCATCACTGTTGCTGGC-3′ 
5′-ATACCTGACCACCTACCCTA-3′ 
 
475 
H3R 
Sense  
Antisense 
 
5′-CCACTTCCACCACACACTTG-3′ 
5′-TGAATGGAGTCCGGAGACGT-3′ 
 
560 
H4R 
Sense 
Antisense 
 
5′-GGAATCTGCATGTTTTGGCT-3′ 
5′-GTCCTTCGATCGGTCCAGTG-3′ 
 
667 
  
68 
 
Hdc 
Sense 
Antisense 
 
5′-TGTGACGTCCCAGTTTACCA-3′ 
5′-TGTCCCAGAAGCACTAGGTG-3′ 
 
777 
Hnmt 
Sense 
Antisense 
 
5′-GTTGTTGAGCCAAGTGCTGA-3′ 
5′-ATCGTTTTGTCGTGGTGACC-3′ 
 
514 
GAPDH* 
Sense 
Antisense 
 
5′-AGAACATCATCCCTGCATCC-3′ 
5′-CACATTGGGGGTAGGAACAC-3′ 
 
91 
Hdc* 
Sense 
Antisense 
 
5′-TCCATTAAGCTGTGGTTTGTGATTC-3′ 
5′-CGCTTCTGACCAGAGATTCAAAGTA-3′ 
 
109 
TNFα* 
Sense 
Antisense 
 
5′-AGTTCTATGGCCCAGACCCT-3′ 
5′-CACTTGGTGGTTTGCTACGA-3′ 
 
385 
PGE2 synthase* 
Sense 
Antisense 
 
5′-GGCCATGGAGTGGACTTAAA-3′ 
5′-AGTGTCTTTGATTGTGGGGG-3′ 
 
146 
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CD68* 
Sense 
Antisense 
 
5′-ACTGGTGTAGCCTAGCTGGT-3′ 
5′-CCTTGGGCTATAAGCGGTCC-3′ 
 
85 
IL-1β* 
Sense 
Antisense 
 
5′-TGCCACCTTTTGACAGTGATG-3′ 
5′-TGATGTGCTGCTGCGAGATT3′ 
 
138 
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6. FIGURE LEDGENDS 
 
Figure 1. Analysis of the purity of primary mouse microglia 
Primary mouse mixed glial cells and primary microglia were stained with anti-CD11b 
(microglial marker protein) (green) and anti-GFAP (astrocytic marker protein) (red). Nucleus 
was stained with DAPI (blue). Scale bar, 250 μm. 
 
Figure 2. Primary mouse microglia express H2R, H3R, Hdc and Hnmt 
A, RT-PCR analysis for mRNA detection of histamine receptor subtypes (H1R–H4R) and 
enzymes for histamine synthesis (Hdc) and metabolism (Hnmt) in primary mouse microglia in 
the absence (LPS -) or presence (LPS +) of 6 h LPS (10 ng/ml) stimulation. B, Desitometric 
analysis was performed with ImageJ software. Each value represents the mean ± SEM for 
individual primary microglia sample (n = 3). After the normalization with the expression 
levels of GAPDH, the average values of non-stimulated cells were set to 1. Each band 
represents a PCR product from a different microglial cell culture. Data are presented as mean 
± standard error of the mean. Differences were identified using Student’s t-tests; *P < 0.05; 
**P < 0.01 
 
Figure 3. LPS-induced histamine production in primary mouse microglia 
A, LPS (10 ng/ml) enhanced mRNA expression levels of Hdc in primary cultured microglia 
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(n = 4). The mRNA expression levels of Hdc were measured by quantitative real-time 
RT-PCR method. Duration of LPS exposure was 6h. B, LPS (10 ng/ml) induced histamine 
production from microglia (n = 4). To determine whether histamine was produced by 
enzymatic activity, microglia were pre-treated with α-FMH (10 μM) 2 h before 24h LPS 
exposure. Data are presented as mean ± standard error of the mean. Differences were 
identified using Student’s t-tests; **, P < 0.01, n.d.: not detected. 
 
Figure 4. Activation of microglial H3R reduces cAMP accumulation  
Effect of amthamine (2–200 µM), imetit (0.1–10 nM) (A) or histamine (0.1–100 µM) (B) on 
forskolin-induced cAMP accumulation in microglia (n = 4). Microglia were pre-incubated 
with each reagent. After 30 min pre-incubation, forskolin was added to the cultures, and 
microglia were incubated for 30 min. Data are presented as mean ± standard error of the mean. 
Differences were identified using One-way ANOVA and multiple comparison; *, P < 0.05. 
 
Figure 5. Activation of microglial H3R inhibits ATP-evoked intracellular Ca
2+
 signals 
Changes in intracellular Ca
2+
 concentration in response to histamine (0.1 µM–1000 mM) (n = 
8) (A), and 1 mM ATP (control: black line) with 10 µM histamine (red line), 250 µM 
histamine (blue line), 200 µM amthamine (purple line) or 10 nM imetit (green line) (n = 8) 
(B). Average fluorescence before adding ATP was set to 1. The results shown are means of 
  
72 
 
fluorescence obtained from 8 wells. Ca
2+
 concentrations after ATP stimulation were shown 
with mean ± SEM. Differences were identified using One-way ANOVA and multiple 
comparison; *, P < 0.05; **, P < 0.01. 
 
Figure 6. Activation of microglial H3R inhibits chemotaxis  
The number of microglia migrated across the transwell membrane after 16 h in the absence or 
presence of ATP (100 μM), histamine (0.1–10 μM), imetit (0.1–10 nM), or thioperamide (thio, 
1 μM) plus histamine (10 μM). Chemotaxis was quantified by counting microglia on the 
underside of the membrane. Data are presented as mean ± standard error of the mean. 
Differences were identified using One-way ANOVA and multiple comparison; *, P < 0.05; **, 
P < 0.01; n.s., not significant. 
 
Figure 7. Activation of microglial H3R inhibits phagocytosis  
A-D, Fluorescent microspheres (red) engulfed by microglia in the absence (A) or presence of 
100 μM UDP (B), 10 μM histamine (C), or 10 nM imetit (D). Microglia were stained with 
anti-actin phalloidin (green). Nuclei were stained with DAPI (blue). Scale bar, 20 μm. Two 
representative experiments are shown. E, Number of engulfed microspheres in the absence or 
presence of UDP (100 μM), histamine (0.1–10 μM), imetit (0.1–10 nM) or thioperamide (thio, 
1 μM thioperamide) plus histamine (10 μM). Phagocytosis was quantified by counting 
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engulfed fluorescent microspheres in microglia. At least 200 microglia were examined from 
each cover slip, and three cover slips were used for each treatment condition. Data are 
presented as mean ± standard error of the mean. Differences were identified using One-way 
ANOVA and multiple comparison; *, P < 0.05; **, P < 0.01; n.s., not significant. 
 
Figure 8. Inhibition of TNFα and PGE2 production by H3R activation 
A, B, LPS-induced (10 ng/ml) mRNA expression of TNFα and PGE2 synthase in primary 
cultured microglia in the absence or presence of histamine (0.1–10 μM), imetit (0.1−10 nM), 
or thioperamide (thio, 1 μM thioperamide) plus histamine (10 μM). Duration of LPS exposure 
was 6h. The mRNA expression levels of TNFα and PGE2 synthase were measured by 
quantitative real-time RT-PCR method. C, D, LPS-induced (10 ng/ml) TNFα and PGE2 
secretion from primary cultured microglia in the absence or presence of histamine (0.1–10 
μM), imetit (0.1−10 nM), or thioperamide (thio, 1 μM thioperamide) plus histamine (10 μM). 
After 24 h exposure of LPS, culture supernatants were collected and assayed for TNFα and 
PGE2. Shown are mean concentrations from 6 wells. Data are presented as mean ± standard 
error of the mean. Differences were identified using One-way ANOVA and multiple 
comparison; *, P < 0.05; **, P < 0.01; n.s., not significant. 
 
Figure 9. H3R agonist increased whereas H3R inverse agonist decreased mRNA expression 
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level of TNFα and PGE2 synthase in in vivo microglia 
The mRNA expression levels of TNFα and PGE2 synthase in isolated microglia from adult 
mouse brain after injection of saline, LPS (1 mg/kg), LPS plus immethridine (Immeth, 10 
mg/kg imethridine: A, B), or LPS plus JNJ (JNJ, 10 mg/kg JNJ10181457: C, D) (n = 3, 4). 
The mRNA expression levels of TNFα and PGE2 synthase in the isolated microglia were 
measured using quantitative real-time RT-PCR. Data are presented as mean ± standard error 
of the mean. Differences were identified using One-way ANOVA and multiple comparison; *, 
P < 0.05; **, P < 0.01. 
 
Figure 10. JNJ suppressed microglial chemotaxis 
A, Representative images of microglial migration induced by the application of 3 mM ATP in 
hippocampal slices from CX3CR1-GFP mice without (upper panels) or with 10 μM JNJ 
pre-treatment (lower panels). ATP was locally applied (T: 0 minutes, left side) and microglial 
responses were observed for 30 minutes (T: 30 minutes, right side). Microglial process 
motility was tracked using colored lines. Scale bars = 100 μm. (B) Quantitative analysis of 
microglial migration. Medium without ATP was applied (black line, n = 3). ATP was applied 
without (blue line, n = 4) or with 10 μM JNJ pre-treatment (Orange line, n = 4). Cumulative 
ratio of fluorescent intensity at each time point was calculated as a bar graph. Data are 
presented as mean ± standard error of the mean. Differences were identified using one-way 
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ANOVA and multiple comparisons tests; *P < 0.05; **P < 0.01. 
 
Figure 11. JNJ suppressed microglial phagocytosis in hippocampal slices  
A, Representative images of CX3CR1- GFP microglia (green) and PI (red) in hippocampal 
slices treated with 50 μM NMDA in the presence or absence of JNJ (1 μM). Scale bars = 100 
μm. B, PI-positive area in GFP-positive microglia with or without JNJ (1 μM) treatment was 
measured (n = 8). C, Representative images of CX3CR1-GFP microglia (green) and 
immunostaining for CD68 (red) in hippocampal slices treated with 50 μM NMDA in the 
presence or absence of JNJ (1 μM). Scale bars = 100 μm. D, CD68-stained area in 
GFP-positive microglia with or without JNJ (1 μM) treatment was measured (n = 4). E, 
mRNA expression levels of CD68 in hippocampal slices treated with 50 μM NMDA in the 
presence or absence of JNJ (1 μM) (n = 4). The mRNA expression levels of CD68 were 
measured using quantitative real-time RT-PCR. Data are presented as mean ± standard error 
of the mean. Differences were identified using Student’s t-tests; *P < 0.05; **P < 0.01. 
 
Figure 12. JNJ suppressed microglial phagocytosis in vivo 
A, CX3CR1-GFP microglia (green) engulfed fluorescent zymosan particles (red) in control, 
JNJ-, LPS-, or LPS- and JNJ-treated mouse prefrontal cortex. Scale bars = 200 μm. B, 
Quantitative analysis of the numbers of engulfed zymosan particles by microglia (n = 3). Data 
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are presented as mean ± standard error of the mean. Differences were identified using 
one-way ANOVA and multiple comparisons tests; *P < 0.05; **P < 0.01. 
 
Figure 13. JNJ treatment suppressed microglial activation and improved depression-like 
behavior 
A, Total immobility time in the tail suspension test after injection of saline, LPS (1 mg/kg), 
JNJ (10 mg/kg), or LPS plus JNJ (n = 6–8). B, IL-1β protein levels in the mouse brain after 
injection of saline, LPS (1 mg/kg), JNJ (10 mg/kg), or LPS plus JNJ (n = 3, 4). The levels of 
IL-1β protein were measured using an enzyme-linked immunosorbent assay. C, mRNA 
expression levels of IL-1β in isolated microglia from adult mouse brain after injection of 
saline, LPS (1 mg/kg), JNJ (10 mg/kg), or LPS plus JNJ (n = 3, 4). The mRNA expression 
levels of IL-1β in the isolated microglia were measured using quantitative real-time RT-PCR. 
Data are presented as mean ± standard error of the mean. Differences were identified using 
one-way ANOVA and multiple comparisons tests; *P < 0.05; **P < 0.01. 
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